Jin Medical International Ltd. (ZJYL) — SEC Filings

Jin Medical International Ltd. (ZJYL) — 22 SEC filings. Latest: 3 (Apr 27, 2026). Includes 17 6-K, 2 20-F, 1 3.

View Jin Medical International Ltd. on SEC EDGAR

Overview

Jin Medical International Ltd. (ZJYL) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 6-K filed on Aug 20, 2025: Jin Medical International Ltd. filed a Form 6-K on August 20, 2025, reporting for the period ending March 31, 2025. The company, incorporated in E9 and headquartered in Changzhou City, Jiangsu Province, China, operates in the orthopedic, prosthetic & surgical appliances & supplies industry. This fil

Sentiment Summary

Across 22 filings, the sentiment breakdown is: 3 bullish, 2 bearish, 17 neutral. The dominant filing sentiment for Jin Medical International Ltd. is neutral.

Filing Type Overview

Jin Medical International Ltd. (ZJYL) has filed 1 3, 17 6-K, 1 20-F/A, 2 20-F, 1 SC 13G with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent SEC Filings (22)

Jin Medical International Ltd. SEC Filing History
DateFormDescriptionRisk
Apr 27, 202633 Filing
Aug 20, 20256-KJin Medical International Ltd. Files 6-K Reportlow
Jul 16, 20256-KJin Medical Starts Production at New Chuzhou Plantlow
Jun 24, 20256-KJin Medical Appoints New Independent Directorlow
Jun 17, 20256-KJin Medical Director Jourdan Frain Departslow
May 6, 20256-KJin Medical Gets Nasdaq Listing Deficiency Noticehigh
Apr 25, 20256-KJin Medical International Ltd. Files Form 6-Klow
Mar 20, 202520-F/AJin Medical Files 20-F/A Amendment for FY2024medium
Jan 24, 202520-FJin Medical International Ltd. Files 2024 Annual Reportmedium
Oct 11, 20246-KJin Medical Starts New China Manufacturing Facilitylow
Jul 26, 20246-KJin Medical International Ltd. Files 6-K Reportlow
May 14, 20246-KJin Medical Regains Nasdaq Filing Compliancemedium
Apr 26, 202420-FJin Medical International Ltd. Files Annual Report on Form 20-Flow
Apr 12, 20246-KJin Medical International Ltd. Files 6-K Reportmedium
Mar 29, 20246-KJin Medical Receives Nasdaq Hearings Panel Decisionmedium
Mar 6, 20246-KJin Medical Regains Nasdaq Public Holder Compliancelow
Mar 1, 20246-KJin Medical International Ltd. Changes Auditormedium
Feb 23, 20246-KJin Medical International Faces Nasdaq Delisting Noticehigh
Feb 14, 2024SC 13GSC 13G Filing
Feb 5, 20246-KJin Medical Announces 20-for-1 Stock Split Effective Feb 8

Risk Profile

Risk Assessment: Of ZJYL's 17 recent filings, 2 were flagged as high-risk, 6 as medium-risk, and 9 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Key Executives

  • Dr. James Jiayuan Tong
  • Jourdan Frain
  • Ziqiang Wang

Industry Context

Jin Medical International Ltd. operates in the orthopedic, prosthetic, and surgical appliances and supplies industry.

Top Tags

sec-filing (5) · 6-K (4) · foreign-private-issuer (3) · corporate-governance (3) · regulatory-filing (2) · manufacturing (2) · expansion (2) · board-appointment (2) · annual-report (2) · compliance (2)

Key Numbers

Jin Medical International Ltd. Key Metrics
MetricValueContext
Fiscal Year End0930Indicates the end of the reporting period for financial statements.
SEC File Number001-41661Identifies the company's registration with the SEC.
Filing Date20250124The date the annual report was submitted to the SEC.
Ordinary Shares Outstanding155,947,100As of September 30, 2023

Related Companies

JMEI · JMED

Frequently Asked Questions

What are the latest SEC filings for Jin Medical International Ltd. (ZJYL)?

Jin Medical International Ltd. has 22 recent SEC filings from Jan 2024 to Apr 2026, including 17 6-K, 2 20-F, 1 3. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ZJYL filings?

Across 22 filings, the sentiment breakdown is: 3 bullish, 2 bearish, 17 neutral. The dominant sentiment is neutral.

Where can I find Jin Medical International Ltd. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Jin Medical International Ltd. (ZJYL) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Jin Medical International Ltd.?

Financial highlights for Jin Medical International Ltd. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.

What is the investment thesis for ZJYL?

The investment thesis for ZJYL includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Jin Medical International Ltd.?

Key executives identified across Jin Medical International Ltd.'s filings include Dr. James Jiayuan Tong, Jourdan Frain, Ziqiang Wang.

What are the main risk factors for Jin Medical International Ltd. stock?

Of ZJYL's 17 assessed filings, 2 were flagged high-risk, 6 medium-risk, and 9 low-risk.

What are recent predictions and forward guidance from Jin Medical International Ltd.?

Forward guidance and predictions for Jin Medical International Ltd. are extracted from SEC filings as they are enriched.

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.